Chloe Thio Lab

  • Research in the Chloe Thio Lab focuses on two areas: HIV-HBV co-infection and the human genetic determinants of HBV and HCV clearance. For our HIV-HBV research, we have projects in Nigeria, Australia and the United States. We’re also leading a multi-center international study examining HIV-HBV co-infection within the ACTG framework. Our HBV and HCV clearance work involves examining polymorphisms in the genes in people who have either recovered from or have a persistent viral hepatitis infection.

    Research Areas: HIV-HBV co-infection, HIV, hepatitis B, genomics, hepatitis C

    Principal Investigator

    Chloe Thio, M.D.